Search hospitals > Ontario > TORONTO
Princess Margaret Cancer Centre
Claim this profileTORONTO, Ontario M5G 2M9
Global Leader in Cancer
Global Leader in Lung Cancer
Conducts research for Pancreatic Cancer
Conducts research for Breast Cancer
Conducts research for Prostate Cancer
988 reported clinical trials
71 medical researchers
Summary
Princess Margaret Cancer Centre is a medical facility located in TORONTO, Ontario. This center is recognized for care of Cancer, Lung Cancer, Pancreatic Cancer, Breast Cancer, Prostate Cancer and other specialties. Princess Margaret Cancer Centre is involved with conducting 988 clinical trials across 546 conditions. There are 71 research doctors associated with this hospital, such as Amit Oza, MD, Lillian Siu, MD, Marcus Butler, and Philippe Bedard.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
HER2 positive
2Lung Cancer
Global LeaderStage IV
Stage III
HER2 positive
Top PIs
Amit Oza, MDPrincess Margaret Cancer Centre5 years of reported clinical research
Expert in Ovarian Cancer
Studies Fallopian Tube Cancer
30 reported clinical trials
50 drugs studied
Lillian Siu, MDPrincess Margaret Cancer Centre7 years of reported clinical research
Studies Lung Cancer
Studies Melanoma
18 reported clinical trials
42 drugs studied
Marcus ButlerPrincess Margaret Cancer Centre9 years of reported clinical research
Studies Melanoma
Studies Cancer
15 reported clinical trials
27 drugs studied
Philippe BedardPrincess Margaret Cancer Centre4 years of reported clinical research
Studies Breast Cancer
Studies Cancer
16 reported clinical trials
27 drugs studied
Clinical Trials running at Princess Margaret Cancer Centre
Breast Cancer
Cancer
Multiple Myeloma
Lung Cancer
Lymphoma
Solid Tumors
Prostate Cancer
Colorectal Cancer
Ovarian Cancer
Melanoma
Sacituzumab Tirumotecan + Pembrolizumab
for Breast Cancer
Researchers want to know if sacituzumab tirumotecan given alone or with pembrolizumab can treat triple negative breast cancer (TNBC). The main goal of this study is to learn if people treated with sacituzumab tirumotecan alone or with pembrolizumab live longer overall or without the cancer growing or spreading compared to people treated with chemotherapy.
Recruiting2 awards Phase 33 criteria
Sacituzumab Tirumotecan + Pembrolizumab
for Breast Cancer
The purpose of this study is to compare sacituzumab tirumotecan as a single agent, and in combination with pembrolizumab, versus Treatment of Physician's Choice (TPC) in participants with hormone receptor positive/human epidermal growth factor receptor-2 negative (HR+/HER2-) unresectable locally advanced, or metastatic, breast cancer. The primary hypotheses are that sacituzumab tirumotecan as a single agent and sacituzumab tirumotecan plus pembrolizumab are superior to TPC with respect to progression-free survival (PFS) per Response Evaluation Criteria in Solid Tumors version 1.1 (RECIST 1.1) by blinded independent central review (BICR) in all participants.
Recruiting2 awards Phase 33 criteria
sac-TMT + Pembrolizumab
for Breast Cancer
This is a randomized, open-label study comparing the efficacy and safety of adjuvant sacituzumab tirumotecan (MK-2870) in combination with pembrolizumab compared to treatment of physician's choice (TPC) in participants with triple-negative breast cancer (TNBC) who received neoadjuvant therapy and did not achieve a pathological complete response (pCR) at surgery. The primary objective is to compare sacituzumab tirumotecan plus pembrolizumab to TPC (pembrolizumab or pembrolizumab plus capecitabine) with respect to invasive disease-free survival (iDFS) per investigator assessment. It is hypothesized that sacituzumab tirumotecan plus pembrolizumab is superior to TPC with respect to iDFS per investigator assessment.
Recruiting2 awards Phase 35 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Princess Margaret Cancer Centre?
Princess Margaret Cancer Centre is a medical facility located in TORONTO, Ontario. This center is recognized for care of Cancer, Lung Cancer, Pancreatic Cancer, Breast Cancer, Prostate Cancer and other specialties. Princess Margaret Cancer Centre is involved with conducting 988 clinical trials across 546 conditions. There are 71 research doctors associated with this hospital, such as Amit Oza, MD, Lillian Siu, MD, Marcus Butler, and Philippe Bedard.
Where is Princess Margaret Cancer Centre located?
**Princess Margaret Cancer Centre Location and Access:**
- **Address:** 610 University Ave, Toronto, ON M5G 2M9.
- **Public Transport:** Accessible via Queen's Park subway station on Line 1, 506 Carlton or 505 Dundas streetcars. The 142 bus provides additional service along University Avenue during rush hours.
- **Drop-off Points:** Murray Street entrance and University Avenue entrance, both wheelchair accessible.
Who should I call to ask about financial aid or insurance network?
The Princess Margaret Cancer Centre offers comprehensive financial assistance and insurance support for patients through various programs:
- **Income Assistance Programs**: Patients can consult a social worker or contact the Psychosocial Oncology clinic at 416-946-4525.
- **Canadian Breast Cancer Support Fund**: Provides up to $1000 for expenses such as transportation, parking, food, home health, prosthetics, supportive care, and rent.
- **Kelly Shires Breast Cancer Foundation**: Offers up to $1000 for similar expenses to those diagnosed with breast cancer.
- **Canadian Cancer Society’s Travel Treatment Fund**: Assists with travel costs based on a financial assessment.
- **Wellspring's Money Matters**: Connects patients with financial counselling for income replacement and drug compensation.
- **Power of Hope Cost Reduction Program**: Aids cancer patients under 40 with fertility preservation treatment costs.
- **POGO Financial Assistance Program**: Supports Ontario families with expenses like accommodation, food, and child care for siblings under 12 during the child's cancer treatment.
- For general inquiries, contact The Princess Margaret Cancer Foundation at 416-946-6560 or toll-free at 1-866-224-6560.
What insurance does Princess Margaret Cancer Centre accept?
The Princess Margaret Cancer Centre accepts Canadian insurance plans, including OHIP and private insurance. OHIP covers most cancer treatment costs, while some expenses might need coverage through private insurance, government programs, or income tax claims. International patients should refer to the UHN International Patient Program (IPP), and private cancer care services may require a referral and can be covered by private insurance or self-pay.
What awards or recognition has Princess Margaret Cancer Centre received?
The Princess Margaret Cancer Centre, located in Toronto, Ontario, is among the top five cancer research centers globally, renowned for its groundbreaking research and exceptional patient care. It boasts a comprehensive clinical trials program, offering numerous trials for different cancer types, with its database frequently updated. The center's innovative work and life-saving research are supported by the Invest in Research program, enhancing its capability to transform patient outcomes worldwide.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.